Why is Orchid Pharma falling/rising?

As of 26-Sep, Orchid Pharma Ltd's stock price is currently at Rs 730.00, reflecting a decrease of Rs 6.8 or 0.92%. The stock has been on a downward trend, having fallen consecutively for the last five days, resulting in a total decline of 7.43% over the past week. Additionally, the stock's performance has been poor over the last month and year, with returns of -5.38% and -46.60%, respectively. The company has reported weak financial results, including a significant drop in operating profit of 19.64% and negative results for three consecutive quarters, which has contributed to a lack of investor confidence. Furthermore, the stock's high institutional holdings of 20.82% indicate that these investors are likely aware of the company's fundamental weaknesses, including a low return on equity and poor debt servicing capability.
In the broader market context, Orchid Pharma's recent performance has significantly underperformed the benchmark, with the Sensex declining only 2.66% over the past week compared to the stock's 7.43% drop. This stark contrast highlights the stock's struggles relative to the overall market. The pharmaceuticals and drugs sector has also seen a decline of 2.35%, indicating a challenging environment for the industry as a whole. Despite the stock's liquidity being sufficient for trading, the falling investor participation, with a drastic drop in delivery volume, suggests a lack of interest in the stock, further exacerbating its price decline.